Veozah vs Venlafaxine: Which Is Better for Menopause Hot Flashes?
Independent editorial research — educational only, not medical advice, and not medically reviewed by a clinician.
Reader-supported: if you book with a provider through our links, we may earn a commission at no extra cost to you. It never changes our medical facts or which option we say fits you. See our full disclosure.
If you’re weighing Veozah vs venlafaxinefor hot flashes, here’s the honest bottom line first: both work, neither is a proven winner, and the “better” one is the one that fits your budget, your other symptoms, and your medical history. Veozah is the newer, FDA-approved, hormone-free hot-flash drug. Venlafaxine is a low-cost antidepressant that clinicians have quietly used for hot flashes for over 20 years. One can cost around $550+ a month. The other can cost under $25.
Veozah (fezolinetant) is FDA-approved for menopause hot flashes. Venlafaxine (Effexor) is an antidepressant used off-label for them. No study has ever compared the two head-to-head. In their separate trials, Veozah cut moderate-to-severe hot flashes by about 2.5 more per day than a placebo, and venlafaxine by about 1.8 more per day. The best pick depends on cost, your other symptoms, and your health history.
Which one fits you?
Veozah may fit you if…
- ✓Your main problem is hot flashes and night sweats (not vaginal dryness or low libido)
- ✓You want a drug that’s FDA-approved for menopause and is not a hormone or an antidepressant
- ✓You can get the required liver blood tests done before starting and at months 1, 2, 3, 6, and 9
- ✓You have insurance that covers it, or you qualify for the savings card
Veozah may not fit you if…
- ✗You need the cheapest option and don’t have coverage
- ✗You have known cirrhosis, abnormal baseline liver labs, or severe kidney disease, or take a CYP1A2-blocking medicine
- ✗You also want help with anxiety, depression, or mood
Venlafaxine may fit you if…
- ✓Cost is the deciding factor — the generic is very cheap
- ✓You also deal with anxiety or low mood, and your clinician thinks an SNRI makes sense
- ✓You’ve had breast cancer and take tamoxifen (more on why below)
Venlafaxine may not fit you if…
- ✗You specifically want a drug that’s FDA-approved for hot flashes
- ✗You don’t want antidepressant side effects like nausea or lower sex drive
- ✗You know you won’t want to taper slowly when it’s time to stop
The 30-second verdict
| Your situation | Better first conversation |
|---|---|
| I want the FDA-approved, non-hormone, non-antidepressant hot-flash drug | Veozah |
| I need the lowest cash price | Venlafaxine |
| I also have anxiety or depression | Venlafaxine (worth discussing) |
| I take tamoxifen after breast cancer | Venlafaxine is the usual go-to; ask about it |
| I can’t or won’t do the required liver blood tests | Not Veozah without a clinician’s plan |
| My main problem is vaginal dryness or painful sex | Neither — ask about GSM treatment instead |
| My insurance denied Veozah | Venlafaxine or another covered option |
Note: Veozah and venlafaxine aren’t your only choices. Two other FDA-approved pills for menopause hot flashes exist — low-dose paroxetine (Brisdelle) and Lynkuet (elinzanetant). More on the alternatives below.
▶ Find My HRT Path — about 90 seconds
Not sure which one fits your situation? Answer a few quick questions about your symptoms, your history, and your budget, and get a personalized starting point — plus an honest flag if online care isn’t the right first step for you yet.
Start Find My HRT Path →Veozah vs venlafaxine: the full comparison
Last verified July 2026. Sources: FDA, DailyMed, The Menopause Society 2023 position statement, published SKYLIGHT and MsFLASH trial data, and 2026 pharmacy pricing. Full source list at the bottom.
| What you’re comparing | Veozah (fezolinetant) | Venlafaxine (generic Effexor XR) |
|---|---|---|
| FDA-approved for hot flashes? | Yes — approved May 2023 for moderate-to-severe hot flashes and night sweats from menopause | No — approved for depression and anxiety; used off-label for hot flashes |
| What kind of drug is it? | A non-hormonal “NK3 blocker” — calms the part of your brain that controls body temperature | An SNRI antidepressant — raises serotonin and norepinephrine |
| Is it a hormone? | No | No |
| Typical dose | One 45 mg pill a day | Start at 37.5 mg, usually up to 75 mg a day |
| How well it works vs placebo | Cut moderate-to-severe hot flashes by ~2.5 more/day at 12 weeks (SKYLIGHT trials); over half of users saw a 50%+ drop | Cut hot flashes by ~1.8 more/day; one trial showed 47.6% drop vs 28.6% on placebo at 8 weeks |
| How fast | Some relief within the first week | Some relief within about 2 weeks |
| Cash price (no insurance) | About $550–$765/month (no generic exists) | About $10–$45/month generic; as low as $4–$10 with a free discount card |
| With insurance | Savings card can drop to $0 first month, ~$30 after (if eligible) | Usually a low-tier generic; copay often $0–$15 |
| Special monitoring | Liver blood tests before starting, then at months 1, 2, 3, 6, and 9 | Blood-pressure checks; no drug-specific lab schedule |
| Serious warning on the label | Boxed warning for rare but serious liver injury (Dec 2024) | Boxed warning for suicidal thoughts in people age 24 and younger |
| Stopping it | No taper needed | Must taper slowly — stopping suddenly can cause withdrawal |
| Helps mood/anxiety too? | No | Yes — a real plus if you also have those symptoms |
Quick definitions
- Off-label — a drug FDA-approved for one thing prescribed for another. Legal, common, and often backed by good research.
- VMS (vasomotor symptoms) — the medical name for hot flashes and night sweats.
- Boxed warning — the FDA’s most serious warning. Not “don’t use this” — it means “know this risk and watch for it.”
Which one actually works better for hot flashes?
Veozah’s evidence.In two large studies (SKYLIGHT 1 and 2), about 1,022 women with at least 7 hot flashes a day took Veozah or a placebo. At 12 weeks, Veozah 45 mg reduced hot flashes by roughly 2.5 more per day than the placebo. Over half the women on it had their hot flashes cut by 50% or more. Relief started showing up in week one.
Venlafaxine’s evidence.In a well-run study of 339 women, venlafaxine (75 mg a day) reduced hot flashes by 47.6% at 8 weeks, compared with 28.6% on placebo — about 1.8 fewer hot flashes per day than placebo. In that same study, venlafaxine worked almost as well as a low dose of estrogen.
Why you can’t just line up the two numbers
| Veozah trial (SKYLIGHT 1 & 2) | Venlafaxine trial (MsFLASH) | |
|---|---|---|
| Women studied | ~1,022 | 339 |
| Starting point | At least 7 hot flashes a day | Frequent daily hot flashes |
| When results were measured | 12 weeks | 8 weeks |
| Placebo group | Also improved (placebo response is high in these trials) | Dropped 28.6% on a dummy pill |
| The headline number | ~2.5 fewer per day than placebo | ~1.8 fewer per day than placebo |
Different sizes, different timelines, different placebo effects. That’s why no honest source ranks one as the “stronger” drug. The real takeaway: if your question is “which is more menopause-specific?” the answer is Veozah. If it’s “which is cheaper and still proven to help?”it’s usually venlafaxine.
Is venlafaxine actually FDA-approved for hot flashes?
Quick answer: No — but “off-label” doesn’t mean unproven.
Venlafaxine is FDA-approved for depression and anxiety, not hot flashes. As of July 2026, the prescription pills the FDA has approved specifically for menopause hot flashes are fezolinetant (Veozah), elinzanetant (Lynkuet), and paroxetine 7.5 mg (Brisdelle).
But off-label doesn’t mean unproven.The Menopause Society’s 2023 review — the guidebook many menopause clinicians follow — gives its highest evidence rating to both fezolinetant and to SNRIs/SSRIs like venlafaxine. So venlafaxine has solid research behind it. It just carries an off-label label because no drug company paid to run FDA-approval studies for a cheap generic.
Why this matters for your decision.If having that official FDA stamp for hot flashes gives you peace of mind, Veozah (or Lynkuet) has the cleaner fit. If you care more about evidence and cost than the paperwork, venlafaxine is still a legitimate, guideline-backed choice. Neither answer is wrong — it’s about what makes you feel confident walking into a consult.
Which is safer — the liver warning or the antidepressant?
Veozah: the liver warning, plainly
⚠ FDA Boxed Warning — Veozah (December 2024)
In December 2024, the FDA added a boxed warning to Veozah about rare but serious liver injury. It’s not common — but it’s serious enough that the label requires a specific plan.
- ›A liver blood test before you start
- ›Repeat tests at months 1, 2, 3, 6, and 9
- ›Stop the drug and call your clinician right away if you notice: new tiredness, nausea, vomiting, itching, yellow skin or eyes, dark urine, pale stools, or pain on the upper-right side of your belly
Veozah is also notfor people with known cirrhosis, severe kidney disease, or anyone taking a CYP1A2-blocking medicine (a common example is the antibiotic ciprofloxacin — your pharmacist can check your list). So the “cost” of Veozah isn’t only money. It’s also a handful of lab visits, especially early on.
Venlafaxine: the antidepressant tradeoffs
- ›Blood pressure. Venlafaxine can nudge blood pressure up, so your clinician should check it before and during treatment.
- ›Boxed warning. A warning about increased suicidal thoughts and behaviors in children, teens, and young adults age 24 and younger. For most women in menopause this risk is lower, but it’s on the label and worth knowing.
- ›Withdrawal. Venlafaxine leaves your body fast (half-life ~5 hours), which means skipping even one dose can cause brain zaps, dizziness, or nausea. You don’t stop it cold turkey — you taper down slowly with your clinician.
- ›Common side effects. Nausea, dry mouth, lower appetite, and reduced sex drive, especially early on.
The monitoring, side by side
| Timeline | Veozah | Venlafaxine |
|---|---|---|
| Before starting | Liver blood test | Blood-pressure check |
| First 3 months | Liver test each month (1, 2, 3) | BP checks as advised |
| Month 6 | Liver test | — |
| Month 9 | Liver test | — |
| Stopping it | Just stop (no taper) | Taper slowly over weeks |
So which side effects are more likely to bug you?
| Concern | More of a Veozah issue | More of a venlafaxine issue |
|---|---|---|
| Start-up and follow-up blood tests | ✅ Yes | — |
| Cost / insurance denial | ✅ Often | Rarely |
| Blood pressure | — | ✅ Yes |
| “I don’t want an antidepressant” | — | ✅ Yes |
| Tapering when you stop | — | ✅ Yes |
| Lower sex drive | — | ✅ Possible |
| Also helps mood/anxiety | Not a goal | ✅ Can help |
Here’s the reassuring part: both drugs are managed by regular women with regular clinicians every day. The liver tests are simple. The blood-pressure checks are simple. The taper is planned. The safety question isn’t really “which one is dangerous?” — it’s “which monitoring plan fits my life, and who’s going to keep an eye on things with me?”
▶ Get a clinician who can actually monitor this
Veozah needs liver labs. Venlafaxine needs blood-pressure checks and a taper plan. Midi Health has clinicians who specialize in women’s midlife health, prescribe bothof these drugs, work with many commercial insurance plans, and can direct you to a local lab for the bloodwork Veozah needs — all by video.
See if you’re a candidate with Midi →How much do Veozah and venlafaxine cost in 2026?
Price snapshot — verified July 2026
| Veozah | Venlafaxine (generic) | |
|---|---|---|
| Cash / retail price | ~$550–$765/month | ~$10–$45/month |
| With a free discount card | Often ~$300–$485/month (brand-only) | As low as ~$4–$10/month |
| With commercial insurance + savings card | As low as $0 first month, ~$30 after (if eligible) | Usually $0–$15 copay |
| Uninsured help | May be $0 through the Astellas Patient Assistance Program if eligible | Generic is already low-cost |
Prices vary by pharmacy and location. Always confirm your exact price before you fill. Brand “Effexor XR” costs much more than generic venlafaxine — ask that your prescription be written for the generic.
Veozah’s real cost includes the labs
Say you’re paying cash for Veozah. That’s roughly $6,600–$9,180 a year in drug alone. Then add the six liver blood tests the label requires in your first year (baseline, plus months 1, 2, 3, 6, and 9). Those tests often run around $30–$50 each without coverage, though the price varies a lot by lab.
So the honest first-year picture is the drug plusthe monitoring. Venlafaxine has no drug-specific lab schedule — just routine blood-pressure checks that any visit covers. The honest comparison is venlafaxine’s roughly $50–$540 a year against Veozah’s drug price plus labs— a much bigger gap than the sticker suggests.
The savings-card catch
Veozah’s copay card can drop the cost to $0 the first month and about $30 for refills— but only if you have commercialinsurance (not Medicare or Medicaid), and it comes with an annual cap and other fine print. If you’re uninsured, you may qualify for the manufacturer’s patient-assistance program, which can provide the drug at no cost for those who are eligible.
What if insurance denies Veozah?
It happens a lot — Veozah often needs prior authorization (your doctor has to justify it to your insurer). If you’re denied, don’t just give up or pay full price. Ask your prescriber about: filing a prior authorization or appeal, the manufacturer savings card, patient assistance, or switching to a lower-cost option like generic venlafaxine. A denial is a fork in the road, not a dead end.
▶ Check the real price before you pay
Don’t get blindsided at the pharmacy counter. A Midi Health clinician can help you plan the coverage, prior-authorization, and lab conversation for either drug — and verify the final price with your insurer, pharmacy, and the manufacturer program before you fill. In a hurry and happy to pay cash? Sesame Care offers cash-pay video visits from around $34.
Who is Veozah best for — and who is venlafaxine best for?
| If this is you… | Lean toward | Why |
|---|---|---|
| Hot flashes are the whole problem; you want a non-hormone, non-antidepressant drug | Veozah | It’s built for exactly this and is FDA-approved for it |
| Cost is your #1 concern / you’re uninsured | Venlafaxine | Pennies compared to Veozah |
| You also have anxiety or depression | Venlafaxine | One prescription can help both |
| You take tamoxifen after breast cancer | Venlafaxine | It only weakly affects the enzyme tamoxifen relies on |
| You can’t do the required blood tests | Not Veozah (without a plan) | The labs aren’t optional |
| You have known cirrhosis, abnormal liver labs, or take a CYP1A2 blocker | Not Veozah | It’s not safe for you — ask about other options |
| You really don’t want an antidepressant | Veozah or another option | Venlafaxine is an antidepressant |
| Your main issue is vaginal dryness or painful sex | Neither | Different problem, different fix (see below) |
If you can’t take hormones, which one should you ask about?
| Why systemic hormones are out | Better first conversation |
|---|---|
| Personal preference; you want non-hormone and non-antidepressant | Veozah |
| Insurance won’t cover Veozah | Venlafaxine or another covered option |
| You’re in active breast cancer treatment or on hormone-blocking therapy | Talk to your oncology + menopause team first — don’t self-route |
| You take tamoxifen | Venlafaxine is a common pick (more below) |
| Mood or anxiety is also in the picture | Venlafaxine may cover both |
| Vaginal dryness or painful sex is the main issue | Neither — ask about GSM treatment, including local vaginal therapy when appropriate |
Important note for breast cancer survivors
Veozah has not been studied in people receiving hormone therapy for breast cancer. If that’s your situation, this is a conversation for a clinician who knows your full cancer history — not a general online sign-up. Venlafaxine is often chosen for women on tamoxifen because it only weakly affects the CYP2D6 enzyme (the one tamoxifen relies on to work), unlike stronger blockers such as paroxetine or fluoxetine. Even so, your oncology team should check your exact medication list before you start anything.
What these two drugs won’t fix
If any of these matches your actual top complaint, neither drug is your answer:
| Your real problem | What it usually needs instead |
|---|---|
| Vaginal dryness | GSM treatment — often local (vaginal) therapy, not a hot-flash pill |
| Painful sex | An evaluation for GSM (genitourinary syndrome of menopause) and appropriate treatment |
| Recurring urinary symptoms | A clinician check — could be several causes |
| Low libido | A broader look at hormones, mood, sleep, relationships, and medications |
| Brain fog or fatigue | Could be sleep, thyroid, iron, mood, or menopause — worth sorting out |
| Bone protection | A bone-health and osteoporosis-risk discussion |
Not sure your problem is even a hot-flash problem? That’s exactly what our quiz is for.
What about Lynkuet and the other new options?
Lynkuet (elinzanetant)
FDA-approved in October 2025 and available in the U.S. since November 2025 for moderate-to-severe hot flashes from menopause. Like Veozah, it’s non-hormonal; unlike Veozah, it blocks two brain receptors (NK1 and NK3). Its trials also looked at sleep disturbance, but its FDA-approved use is hot flashes — not standalone insomnia. A manufacturer copay card can bring it to as little as $25/month for eligible, commercially insured patients. If Veozah interests you but you also struggle with sleep, Lynkuet is worth asking about.
The other FDA-approved-for-hot-flashes pill. It’s a low-dose antidepressant, a cousin of venlafaxine, but at a dose meant for hot flashes, not depression. Unlike venlafaxine, paroxetine strongly blocks the CYP2D6 enzyme that tamoxifen relies on — so it’s typically avoided for women on tamoxifen.
A prescription-only, off-label option that some clinicians like, especially for night sweats.
How do you get Veozah or venlafaxine online?
Where a menopause telehealth clinic fits
Midi Health — our default suggestion for this decision
- ›Midi’s clinicians prescribe both Veozah and venlafaxine — so you’re not boxed into one before you’ve decided
- ›Available in all 50 states and works with many major commercial insurance plans (coverage varies by plan)
- ›Can direct you to a local lab (often Labcorp) for the bloodwork Veozah requires
- ›Clinicians regularly help women who can’t take hormones — including breast cancer survivors
One honest limitation about Midi
Midi does notwork with Medicare or Medicaid, and it can’t treat Medicaid or Medi-Cal patients even on a cash-pay basis. Its cash prices are $250 for a first visit and $150 for follow-ups(labs and medications are extra). If you’re on Medicare or Medicaid, Midi isn’t your route — a cash-pay option like Sesame or an in-person clinician makes more sense.
If speed and a flat cash price matter more to you than insurance and lab coordination, Sesame Careis the better fit — its menopause care is cash-pay (about $99/month, or a one-off video visit from around $34), and its providers can prescribe non-hormonal options like venlafaxine when appropriate.
Midi vs Sesame, side by side
Verified July 2026. Confirm current details at intake.
| Midi Health | Sesame Care | |
|---|---|---|
| Payment model | Insurance + cash | Cash-pay only (no insurance billed) |
| States | All 50 | Nationwide marketplace (availability varies by area) |
| Medicare / Medicaid | Not accepted; can’t treat Medicaid/Medi-Cal even self-pay | N/A (cash-pay) |
| Cash price | $250 first visit, $150 follow-ups (labs/meds extra) | Menopause subscription ~$99/mo, or one-off visit from ~$34 |
| Prescribes Veozah + venlafaxine? | Yes — both | Non-hormonal prescriptions during a visit when appropriate |
| Labs | Directs you to a local lab (often Labcorp) | Included if needed (usually Quest) |
| Best for | Insurance + lab coordination, more complex cases | Speed + cash-pay simplicity |
| Confirm at intake | Your plan’s coverage; how Veozah’s labs are tracked | Provider availability near you; whether they’ll manage Veozah’s lab schedule |
What one woman shared
“It was so relieving to have Midi on my side, coming up with solutions.”
One patient’s experience published on Midi’s website — shared here as a real, attributable story, not a promise of typical results, and not evidence that either drug works for everyone.
Verify before you fill — screenshot this for your appointment
- ›Is this covered by my insurance, or will I pay cash?
- ›Is prior authorization needed? What happens if I’m denied after the first fill?
- ›Am I eligible for the savings card, and what’s the yearly cap?
- ›For Veozah: which labs do I need, and where do I get them at months 1, 2, 3, 6, and 9?
- ›For Veozah: do any of my current meds block CYP1A2?
- ›For venlafaxine: is this the immediate-release or extended-release version, and what dose?
- ›For venlafaxine: what’s the plan to taper if I want to stop?
- ›How long should I give it before deciding it isn’t working?
What should you ask your doctor before you choose?
Sometimes the hardest part is knowing how to bring it up. Steal these.
If you want to avoid antidepressants:
“My main symptoms are hot flashes and night sweats. I know venlafaxine can be used off-label, but I’m worried about antidepressant side effects and the taper. Can we talk about whether Veozah — or another non-hormone, non-antidepressant option — is right for me, and what labs or coverage I’d need to check?”
If Veozah is too expensive:
“Veozah seems like a good fit because it’s FDA-approved for hot flashes, but I’m worried about the cost and coverage. If my plan denies it or the savings card doesn’t work, what lower-cost options should we discuss — including venlafaxine?”
If you’re not even sure a hot-flash pill is the answer:
“I’m comparing Veozah and venlafaxine, but I want to make sure we’re not skipping the bigger picture. Based on my age, whether I have a uterus, my risk history, and my symptoms, should we also talk about hormone therapy or vaginal (local) estrogen?”
Frequently asked questions
- Is Veozah the same as venlafaxine?
- No. Veozah (fezolinetant) is a non-hormonal NK3 blocker that is FDA-approved for menopause hot flashes. Venlafaxine (Effexor) is an SNRI antidepressant used off-label for hot flashes. They work through completely different mechanisms.
- Is venlafaxine FDA-approved for hot flashes?
- No. Venlafaxine is FDA-approved for depression and anxiety and used off-label for hot flashes. As of July 2026, the FDA-approved pills specifically for menopause hot flashes are fezolinetant (Veozah), elinzanetant (Lynkuet), and paroxetine 7.5 mg (Brisdelle) — though The Menopause Society still gives venlafaxine its top evidence rating.
- Is Veozah an antidepressant?
- No. Veozah is not an antidepressant and not a hormone. It is a neurokinin 3 (NK3) receptor blocker approved for moderate-to-severe hot flashes and night sweats due to menopause.
- Which is cheaper, Veozah or venlafaxine?
- Venlafaxine, by a wide margin. Generic venlafaxine runs about $10–$45 a month, or as low as $4–$10 with a free discount card. Veozah runs about $550–$765 a month without insurance, though a savings card may lower it for eligible, commercially insured patients.
- Can I take Veozah and venlafaxine at the same time?
- Do not combine or change prescription drugs based on a web page. A clinician or pharmacist needs to review your full medication list, liver history, and blood pressure first. There is no reason to assume you would need both for hot flashes.
- Does venlafaxine help night sweats?
- Yes. Night sweats are nighttime hot flashes, and venlafaxine reduces both. In one trial, 75 mg a day cut hot flashes and night sweats significantly more than a placebo over 8 weeks.
- Will Veozah help my anxiety?
- No — Veozah treats hot flashes, not mood or anxiety. If anxiety is a major symptom for you, that is a separate conversation, and it is one reason some women choose venlafaxine instead.
- What blood tests do I need for Veozah?
- A liver blood test before you start, then repeat tests at months 1, 2, 3, 6, and 9 — or sooner if you notice symptoms of liver trouble. This monitoring is required by the label because of the boxed liver warning added in December 2024.
- How long until each one works?
- Both can start helping within the first couple of weeks. Veozah showed improvement within the first week in trials; venlafaxine often within about two weeks. Ask your clinician how long to give it before deciding — usually weeks, not days.
- Is hormone therapy still more effective than both?
- Yes. The Menopause Society states that hormone therapy remains the most effective treatment for hot flashes for women who can safely use it. Veozah and venlafaxine matter most for women who cannot or do not want to use hormones.
- What if my insurance denies Veozah?
- Ask your prescriber about prior authorization, an appeal, the manufacturer savings card, patient assistance, or a lower-cost alternative like generic venlafaxine. Don’t start an unaffordable drug without knowing what happens after the first fill.
The bottom line
There’s no universal winner here — and any page that tells you otherwise is bluffing, because no study has ever compared these two drugs directly. Veozah is the newer, FDA-approved, non-hormone hot-flash drug: strong evidence, not an antidepressant and not designed to treat mood, but pricey, with required liver labs. Venlafaxineis the cheap, guideline-backed, off-label choice that can help mood too — as long as you’re okay with an antidepressant and a slow taper when you stop.
Match the drug to your life: your budget, your other symptoms, your health history, and whether you can take hormones at all. Then bring a clear question to a clinician who treats menopause every day.
Still not sure which option fits you? Take our free Find My HRT Path quiz — about 90 seconds. It matches your symptoms, history, and budget to the right next step, and it’ll tell you honestly if online care isn’t the right starting point for you yet.
Find My HRT Path →✓ What we actually verified for this page
We’re The HRT Index — the independent menopause HRT decision layer for women.For this comparison, our editorial team read the FDA prescribing information and boxed warnings for both drugs, The Menopause Society’s 2023 non-hormone position statement, the published SKYLIGHT and MsFLASH trial results, and current cash and insured prices from multiple pharmacy sources. FDA-approved (Veozah) and off-label (venlafaxine) status are labeled clearly throughout. Prices were verified in July 2026; lab-cost figures are approximate and vary by provider. This page is editorial research, not medical advice, and was not reviewed by a clinician.
Under The HRT Index Verification Standard, we checked:
- 1.Clinical legitimacy — FDA labels, the FDA’s liver-injury safety update, and Menopause Society guidance
- 2.Care quality — what monitoring a responsible clinician should do before prescribing either drug
- 3.Medication fit — FDA-approved vs off-label, hormone vs non-hormone, and which symptoms each treats
- 4.Price transparency — cash prices, savings-card terms, and the often-hidden cost of Veozah’s labs
- 5.Access — insurance, Medicare/Medicaid limits, prior-authorization friction, and when online care isn’t the right first step
We do not assign numeric scores to drugs or providers.
What we did not verify:your personal insurance formulary; your labs, blood pressure, or medication list; or any direct head-to-head trial of Veozah versus venlafaxine — because none exists. We also did not use forum or social-media posts as medical evidence.
Sources
Medical, regulatory, and pricing sources (9)
- 1.U.S. FDA — Veozah (fezolinetant) approval (May 2023); drug-safety communication on serious liver injury (Dec 2024).
- 2.DailyMed / National Library of Medicine — Veozah prescribing information (label updated Feb 26, 2026); venlafaxine prescribing information.
- 3.U.S. FDA — Effexor XR (venlafaxine) label.
- 4.The Menopause Society — 2023 Nonhormone Therapy Position Statement.
- 5.Lederman S, et al. — Fezolinetant for moderate-to-severe vasomotor symptoms (SKYLIGHT 1), and pooled SKYLIGHT analyses. PubMed.
- 6.Joffe H, et al. — Low-dose estradiol and venlafaxine for vasomotor symptoms (MsFLASH), JAMA Internal Medicine, 2014.
- 7.Bayer — Lynkuet (elinzanetant) FDA approval and information.
- 8.Pricing — GoodRx (Veozah), GoodRx (venlafaxine), Drugs.com (venlafaxine), and manufacturer savings pages (Veozah). Verified July 2026.
- 9.Provider information — Midi Health (service scope, insurance, Medicare/Medicaid limits, cash pricing); Sesame Care (menopause care, pricing, prescriptions). Verified July 2026.
Affiliate disclosure: The HRT Index is reader-supported. If you book with a provider through our links, we may earn a commission at no additional cost to you. This never affects our medical facts, our verification, or which option we say fits you. Find My HRT Path collects sensitive health information and is handled under our consumer-health-data and privacy policy.
Last verified: July 2026. Pricing, insurance coverage, savings-card terms, FDA labeling, and provider availability can change. The HRT Index re-checks top medication and provider pages monthly and full comparison pages quarterly under The HRT Index Verification Standard.